Elgethun Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.15M Sell
6,218
-282
-4% -$52.3K 0.23% 51
2025
Q1
$1.36M Sell
6,500
-631
-9% -$132K 0.3% 46
2024
Q4
$1.27M Buy
7,131
+20
+0.3% +$3.55K 0.31% 47
2024
Q3
$1.4M Buy
7,111
+19
+0.3% +$3.75K 0.33% 45
2024
Q2
$1.22M Sell
7,092
-153
-2% -$26.2K 0.31% 52
2024
Q1
$1.3M Buy
7,245
+20
+0.3% +$3.6K 0.33% 51
2023
Q4
$1.12M Buy
7,225
+251
+4% +$38.9K 0.32% 53
2023
Q3
$1.04M Buy
6,974
+27
+0.4% +$4.01K 0.31% 55
2023
Q2
$936K Buy
6,947
+28
+0.4% +$3.77K 0.28% 57
2023
Q1
$1.1M Buy
6,919
+27
+0.4% +$4.31K 0.35% 55
2022
Q4
$1.12M Buy
6,892
+33
+0.5% +$5.35K 0.4% 52
2022
Q3
$920K Buy
6,859
+1,149
+20% +$154K 0.37% 51
2022
Q2
$872K Buy
5,710
+40
+0.7% +$6.11K 0.34% 53
2022
Q1
$919K Buy
5,670
+42
+0.7% +$6.81K 0.31% 52
2021
Q4
$754K Buy
5,628
+47
+0.8% +$6.3K 0.26% 61
2021
Q3
$602K Buy
5,581
+91
+2% +$9.82K 0.21% 64
2021
Q2
$618K Buy
5,490
+46
+0.8% +$5.18K 0.21% 63
2021
Q1
$589K Buy
5,444
+691
+15% +$74.8K 0.23% 59
2020
Q4
$509K Hold
4,753
0.22% 60
2020
Q3
$416K Hold
4,753
0.23% 58
2020
Q2
$467K Hold
4,753
0.27% 57
2020
Q1
$362K Hold
4,753
0.2% 64
2019
Q4
$421K Hold
4,753
0.21% 63
2019
Q3
$354K Hold
4,753
0.19% 65
2019
Q2
$346K Hold
4,753
0.19% 67
2019
Q1
$383K Hold
4,753
0.22% 67
2018
Q4
$424K Sell
4,753
-84
-2% -$7.49K 0.29% 69
2018
Q3
$461K Sell
4,837
-50
-1% -$4.77K 0.3% 67
2018
Q2
$452K Sell
4,887
-325
-6% -$30.1K 0.32% 67
2018
Q1
$493K Hold
5,212
0.34% 68
2017
Q4
$504K Sell
5,212
-230
-4% -$22.2K 0.35% 63
2017
Q3
$484K Hold
5,442
0.36% 60
2017
Q2
$395K Sell
5,442
-117
-2% -$8.49K 0.31% 63
2017
Q1
$362K Sell
5,559
-172
-3% -$11.2K 0.29% 64
2016
Q4
$359K Buy
+5,731
New +$359K 0.28% 60